Cramer vs. Chaikin: You Can't Trade Allergan
TheStreet's Jim Cramer and Marc Chaikin, of Chaikin Analytics, spent an hour together at our offices talking all things markets. Listen to the whole conversation below. In the except above, they discuss Allergan and why you can't trade it.
It's not often you get two powerhouses to sit down and discuss their investing strategies, hottest stocks picks, earnings, the economy and more. Investors of any age can learn from this powerful one hour conversation with TheStreet's Jim Cramer and Marc Chaikin of Chaikin Analytics.
In the video above, they tackle Allergan (AGN) - Get Report (also in Jim Cramer's AAP portfolio). Cramer actually looks to Chaikin for advice on the stock.
"You can't trade them," says Chaikin, referring to not just Allergan, but all the big biotechs.
Listen to Chaikin explain why.
You can watch Cramer and Chaikin's free Webinar here.
Watch More of Cramer vs. Chaikin:
- Cramer vs. Chaikin: Amazon is 'the Ultimate Elephant Stock In the Room'
- Cramer vs. Chaikin: 'Leave Emotion Out of Trading Apple'
- Cramer vs. Chaikin: Here's Why JPMorgan Is a Better Bet Than Goldman
- Cramer vs. Chaikin: Here's What to Look for in Facebook's Earnings Release
- Cramer vs. Chaikin: Nvidia Is a Great Company, but It Might Not Be a Great Stock
